• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 1912997
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/08/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that lower than expected vitros thyroid stimulating hormone (tsh) results were obtained from two different patient samples processed using vitros tsh reagent on a vitros 5600 integrated system.The results were deemed lower than expected when compared to tsh results obtained from an external laboratory electrochemiluminescence test method.For patient sample 1, the lower than expected vitros tsh results were caused by biotin interference in the sample as it was found that the patient was taking a daily 10mg biotin supplement.In (b)(6) 2018, ortho issued a customer communication to alert customers that biased results may occur for specific vitros immunodiagnostic products (microwell assays) at biotin concentrations which are lower than indicated in the current instructions for use (ifu).For the vitros tsh assay, a negative bias may be observed (= 10% bias) in samples with a biotin concentration of 5 ng/ml (0.5 ug/dl).Therefore, a sample interferent that affects the vitros tsh assay was the likely assignable cause of the event for patient sample 1.For patient sample 5, the difference between results is likely due to the different testing methods as the external testing facility utilizes an electrochemiluminescence testing method while vitros tsh is a chemiluminescence based assay and the two different methods can give different results for the same samples.Based on historical quality control results a vitros tsh reagent lot 5855 performance issue is not a likely contributor to the event.Additionally, continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros tsh reagent lot 5855.The customer performed within run precision testing using a vitros total thyroid control and two low dose patient samples.All testing yielded results that were within acceptable guidelines indicating the vitros 5600 integrated system was performing as expected and therefore, an instrument issue is not a likely contributing factor to this event.
 
Event Description
A customer reported multiple vitros thyroid stimulating hormone (tsh) patient sample results that did not correlate when compared to a different, external laboratory test method (electrochemiluminescence testing).The patient samples were processed using vitros tsh reagent in combination with a vitros 5600 integrated system.Patient sample 1 results of 0.053, 0.089, 0.069, 0.074, 0.077, 0.091 miu/ml versus a true result of 1.480 miu/ml patient sample 5 results of <0.015 miu/ml (5 replicates) versus a true result of 0.07 miu/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The initial vitros result for patient sample 1 of 0.053 miu /ml was questioned by a physician who requested comparison testing to be carried out.No patient treatment has been altered based on the observed results.There was no allegation of patient harm as a result of this event.This report is number 2 of 2 mdr¿s for this event.Two (2) 3500a forms are being submitted for this event as 2 devices were involved.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key8579739
MDR Text Key203840711
Report Number3007111389-2019-00077
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 05/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/15/2019
Device Catalogue Number1912997
Device Lot Number5855
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 04/08/2019
Initial Date FDA Received05/03/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/17/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-